ARZERRA - 0173-0821-01 - (ofatumumab)

Alphabetical Index


Drug Information of ARZERRA

Product NDC: 0173-0821
Proprietary Name: ARZERRA
Non Proprietary Name: ofatumumab
Active Ingredient(s): 20    mg/mL & nbsp;   ofatumumab
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of ARZERRA

Product NDC: 0173-0821
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA125326
Marketing Category: BLA
Start Marketing Date: 20110722

Package Information of ARZERRA

Package NDC: 0173-0821-01
Package Description: 1 VIAL in 1 CARTON (0173-0821-01) > 50 mL in 1 VIAL

NDC Information of ARZERRA

NDC Code 0173-0821-01
Proprietary Name ARZERRA
Package Description 1 VIAL in 1 CARTON (0173-0821-01) > 50 mL in 1 VIAL
Product NDC 0173-0821
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ofatumumab
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20110722
Marketing Category Name BLA
Labeler Name GlaxoSmithKline LLC
Substance Name OFATUMUMAB
Strength Number 20
Strength Unit mg/mL
Pharmaceutical Classes CD20-directed Cytolytic Antibody [EPC]

Complete Information of ARZERRA


General Information